Rein Therapeutics (RNTX) Return on Assets (2017 - 2025)
Rein Therapeutics (RNTX) has disclosed Return on Assets for 9 consecutive years, with 1.09% as the latest value for Q3 2025.
- On a quarterly basis, Return on Assets fell 82.0% to 1.09% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.09%, a 82.0% decrease, with the full-year FY2024 number at 0.77%, down 52.0% from a year prior.
- Return on Assets was 1.09% for Q3 2025 at Rein Therapeutics, down from 1.07% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.18% in Q1 2024 to a low of 1.23% in Q1 2023.
- A 5-year average of 0.72% and a median of 0.78% in 2024 define the central range for Return on Assets.
- Peak YoY movement for Return on Assets: soared 105bps in 2024, then crashed -88bps in 2025.
- Rein Therapeutics' Return on Assets stood at 0.51% in 2021, then plummeted by -117bps to 1.12% in 2022, then surged by 76bps to 0.27% in 2023, then tumbled by -191bps to 0.78% in 2024, then plummeted by -40bps to 1.09% in 2025.
- Per Business Quant, the three most recent readings for RNTX's Return on Assets are 1.09% (Q3 2025), 1.07% (Q2 2025), and 1.06% (Q1 2025).